About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials in Chicago | 112 Studies

Clinical Trials Multiple SclerosisChicago

Multiple Sclerosis Clinical Trials in Chicago

Find 112 clinical trials for multiple sclerosis near Chicago, Illinois. Connect with research centers in your area.

All Multiple Sclerosis trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 112 trials

CompletedRebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple SclerosisThe primary objective of the study is to assess the clinical efficacy of Rebif® 44 microgram (mcg) three times per week compared with Copaxone® 20 milligram (mg) daily in subjects…NCT00078338·Birmingham, Alabama and 79 others

Multiple Sclerosis Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedEffects of High-intensity Gait Training on Fatigue, Gait, and Neuroplasticity in People With Multiple SclerosisNearly 1 million individuals in the United States have multiple sclerosis, which causes fatigue and problems with walking.NCT06264336·Chicago, Illinois

CompletedImmunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple SclerosisOur goal is the elucidation of the mechanisms of action of autologous hematopoietic stem cell transplant (HSCT) and immunoablation by high-dose cyclophosphamide in multiple…NCT00342134·Chicago, Illinois and 1 other

Active not recruitingLifestyle Physical Activity Intervention for Persons Newly Diagnosed With Multiple SclerosisThe overall objective of the current study is to determine the efficacy of a 16-week remotely delivered lifestyle behavioral intervention compared with a control condition (i.e.…NCT06355804·Chicago, Illinois

CompletedExtension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron® to Treat Relapsing-remitting Multiple SclerosisThe purpose of this study is to determine if a higher dose of study drug is more effective in preventing relapses in patients with Multiple Sclerosis.NCT00235989·Los Angeles, California and 16 others

CompletedDimethyl Fumarate (DMF) Observational StudyThe primary objective of the study is to determine the incidence, type, and pattern of serious adverse events (SAEs), including but not limited to infections (including…NCT02047097·Birmingham, Alabama and 467 others

Not yet recruitingPhysical Activity Intervention for Individuals Newly Diagnosed With MSThe proposed study is a parallel-group randomized controlled trial (RCT) designed to establish the behavioral mechanism underlying a 16-week physical activity (PA) behavioral…NCT07731659·Chicago, Illinois

TerminatedA Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Participants With Secondary Progressive Multiple SclerosisThis is a Phase 3b, multicenter, international study conducted in 2 parts.NCT01416181·Phoenix, Arizona and 160 others

CompletedA Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving OcrelizumabThis study will evaluate the pharmacokinetics of ocrelizumab in the breastmilk of lactating women with clinically isolated syndrome (CIS) or multiple sclerosis (MS) \[in line with…NCT04998851·San Francisco, California and 7 others

Active not recruitingLong-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MSThe purpose of this study is to collect long-term safety, tolerability, effectiveness and health outcomes data in eligible subjects who have participated in a Novartis ofatumumab…NCT03650114·Birmingham, Alabama and 294 others

RecruitingEffects of Acute Intermittent Hypoxia on Neuroplasticity in MSThis study seeks to explore changes in the neural pathways and arm function following a breathing intervention in the multiple sclerosis (MS) population.NCT06390930·Chicago, Illinois

CompletedPhase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple SclerosisOBJECTIVES: I.NCT00017628·Chicago, Illinois and 1 other

CompletedTysabri Effects on Cognition and Neurodegeneration in Multiple SclerosisThe long-term objective is to further establish the role of Tysabri in preventing neurological degeneration in multiple sclerosis (MS) and to establish powerful and efficient new…NCT01071512·Chicago, Illinois

TerminatedEffect of MD1003 in Progressive Multiple Sclerosis (SPI2)The purpose of this study is to demonstrate the superiority of MD1003 over placebo in the disability of patients suffering from progressive multiple sclerosis and especially those…NCT02936037·Phoenix, Arizona and 91 others

CompletedStress Management for Patients With Multiple SclerosisThere is a growing body of literature showing that stressful life events can increase the risk of developing exacerbations and new brain lesions among people with multiple…NCT00147446·San Francisco, California and 2 others

RecruitingA Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)The purpose of this study is to evaluate safety, effiectiveness, and to gain insight into the treatment experience of participants prescribed BRIUMVI® (ublituximab-xiiy) in the…NCT06433752·Birmingham, Alabama and 110 others

CompletedExploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)Evaluate the safety and efficacy of Siponimod (BAF312) versus placebo in a variable treatment duration in patients with secondary progressive multiple sclerosis (Core Part)…NCT01665144·Phoenix, Arizona and 289 others

TerminatedFeasibility of Remote Exercise Training for Hispanics/Latinos With MSThe goal of this clinical trial is to investigate the potential benefits of a specially designed exercise program for Hispanics/Latinos with multiple sclerosis (MS).NCT05998616·Chicago, Illinois

UnknownFall Prevention Program for Non-ambulatory Wheeled Mobility Device Users Living With MSA research study to examine the effectiveness of a fall management program to prevent falls and develop fall recovery strategies for wheeled mobility device users living with…NCT03705364·Atlanta, Georgia and 2 others

CompletedExamining the Effects of a Remotely-delivered, Racially-tailored Exercise Training Program for Immediate and Sustained Improvements in Walking Dysfunction, Symptoms, and Health-related Quality of Life (HRQOL) Among African-Americans With Multiple Sclerosis (MS) Residing in Rural Environments.The proposed project involves a high-quality randomized controlled (RCT) design that examines the effects of a remotely-delivered, racially-tailored exercise training program for…NCT05516537·Chicago, Illinois

PreviousPage 4 of 6Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia